Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
8.81
+0.39 (4.63%)
At close: Dec 5, 2025, 4:00 PM EST
8.70
-0.11 (-1.25%)
After-hours: Dec 5, 2025, 7:46 PM EST
Verrica Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -26.01 | -76.58 | -67 | -24.49 | -35.08 | -42.69 | |
| Depreciation & Amortization | 0.84 | 1.27 | 0.84 | 0.72 | 0.47 | 0.23 | |
| Loss (Gain) From Sale of Assets | 0.19 | 0.08 | 2.54 | - | - | - | |
| Asset Writedown & Restructuring Costs | 0.26 | 0.26 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | - | - | - | 0.11 | 0.07 | -0.14 | |
| Stock-Based Compensation | 3.39 | 7.16 | 14.38 | 4.99 | 6.05 | 9.82 | |
| Other Operating Activities | 4.59 | 4.85 | 0.81 | 1.83 | 1.44 | 0.94 | |
| Change in Accounts Receivable | -7.4 | 4.34 | -3.93 | -0.49 | - | - | |
| Change in Accounts Payable | 0.62 | -0.57 | 2.2 | -0.34 | 0.5 | -0.84 | |
| Change in Unearned Revenue | 1.56 | - | - | - | -0.5 | 0.5 | |
| Change in Other Net Operating Assets | -7.3 | -1.74 | 11.59 | -0.98 | -0.53 | 1.97 | |
| Operating Cash Flow | -29.1 | -60.93 | -38.58 | -18.65 | -27.58 | -30.21 | |
| Capital Expenditures | - | -0.03 | -0.36 | -0.3 | -0.88 | -1.47 | |
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | - | |
| Investment in Securities | - | - | - | 54.52 | 0.09 | -1.89 | |
| Other Investing Activities | - | - | - | -0.18 | -0.2 | -0.22 | |
| Investing Cash Flow | 0.01 | -0.02 | -0.36 | 54.04 | -1 | -3.58 | |
| Long-Term Debt Issued | - | - | 44.11 | - | 4.98 | 34.46 | |
| Long-Term Debt Repaid | - | -0.92 | -0.02 | -43.75 | -0.01 | - | |
| Net Debt Issued (Repaid) | -12.57 | -0.92 | 44.08 | -43.75 | 4.97 | 34.46 | |
| Issuance of Common Stock | 39.64 | 39.79 | 30.31 | 26.9 | 28.68 | 0.45 | |
| Other Financing Activities | 0.16 | -1.14 | -0.18 | -0.02 | - | 0.32 | |
| Financing Cash Flow | 27.23 | 37.73 | 74.21 | -16.87 | 33.65 | 35.23 | |
| Net Cash Flow | -1.86 | -23.22 | 35.27 | 18.52 | 5.07 | 1.45 | |
| Free Cash Flow | -29.1 | -60.95 | -38.94 | -18.95 | -28.47 | -31.68 | |
| Free Cash Flow Margin | -94.39% | -805.63% | -759.93% | -209.83% | -237.21% | - | |
| Free Cash Flow Per Share | -3.31 | -11.77 | -8.59 | -5.55 | -10.53 | -12.67 | |
| Cash Interest Paid | 6.09 | 7.23 | 3.15 | 1.79 | 2.85 | 1.88 | |
| Levered Free Cash Flow | -25.02 | -35.91 | -17.12 | -11.08 | -18 | -16.9 | |
| Unlevered Free Cash Flow | -19.53 | -30.03 | -14.64 | -9.73 | -15.32 | -15.01 | |
| Change in Working Capital | -12.35 | 2.03 | 9.86 | -1.8 | -0.54 | 1.64 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.